Kestra Medical Technologies, Ltd
Price
FilingsNewest: 10-Q, Quarterly reportSep 14 →Insiders1 insider bought $199,800 in 1 open-market buy. 2 insiders sold $2.6M, all 11 sales on a 10b5-1 plan.→Financing →PeersClosest companies: BVS, LUNG, PRCT→
From the filings
Figures
- Revenue
- $106.7Mlast 12 months
- Net income
- −$149.9Mlast 12 months
- Operating cash flow
- −$87.7Mlast 12 months
- Cash and equivalents
- $68.6Mat the last balance sheet
- Total debt
- $72.5Mat the last balance sheet
- Shares outstanding
- 59.3M shareson issue